Clinical trial Recruiting at 1 site Observational Ages Any age to 17

Evaluating protein levels in children undergoing cardiac surgery

Official title: Evaluation of the Levels of O-GlcNAcylation of Cardiac and Blood Proteins in Paediatric Cardiac Surgery and Identification of Therapeutic Targets

Run by Nantes University Hospital · NCT06754709 · Data updated 2026-11-12

This study is testing how certain protein levels in children having heart surgery might relate to their recovery and complications after the operation.

Quick facts

Study typeObservational
AgesAny age to 17 Years
SexAll
Enrollment300 (estimated)
SponsorNantes University Hospital
Academic / other
Locations1 site (Nantes)
StatusRecruiting
StartedFebruary 13, 2025
Main results expectedJanuary 31, 2034
Study endsJanuary 31, 2035
Registry record updatedApril 13, 2025
Trial IDNCT06754709 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 0 to 17 years who are scheduled for cardiac surgery involving extracorporeal circulation.

Probably not a fit

Patients with infections, fever, immune deficiencies, autoimmune diseases, metabolic diseases, hematological diseases, or genetic diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on children aged 0 to 17 years who are undergoing cardiac surgery with extracorporeal circulation (ECC). It aims to evaluate the levels of blood and cardiac protein O-GlcNAcylation, which may play a role in the inflammatory response and complications associated with ECC. The study seeks to understand how these protein levels correlate with postoperative outcomes, particularly in relation to low cardiac output syndrome and other complications. By identifying potential biomarkers, the research could pave the way for new therapeutic strategies to improve patient outcomes following cardiac surgery.

Why it matters

Potential benefit: If successful, this study could lead to improved management strategies for children undergoing cardiac surgery, potentially reducing complications and enhancing recovery.

How similar studies have gone: While the specific approach of evaluating O-GlcNAcylation in this context may be novel, studies on inflammatory responses and cardiac surgery complications have shown varying degrees of success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age from 0 to 17 years at the time of sampling
* Children undergoing CEC for cardiac surgery
* Signed bio-collection consent

Exclusion Criteria:

* Children with an infection
* Children with fever
* Children with an immune deficiency
* Children with autoimmune disease
* Children with metabolic disease
* Children with haematological diseases
* Children with a genetic disease
* Unsigned consent
* Refusal by parents or child

Where it's running

  • Nantes University Hospital
    Nantes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.